Correlation of Serum Ferritin and Cardiac Iron Toxicity with Cardiac Function in Transfusion Dependent Beta-Thalassemia Major Patients
Background: Cardiac iron toxicity is a major cause of mortality in transfusion-dependent beta-thalassemia major patients. The main modality for detecting cardiac iron toxicity is MRI T2* with limited availability. This study aims to obtain iron toxicity profiles in transfusion-dependent beta-thalassemia patients; to see a correlation between iron toxicity and cardiac function. Methods: We conducted a cross-sectional study at the Adult Thalassemia Polyclinic of Cipto Mangunkusumo Hospital, Indonesia from December 2017 to March 2018. We performed the statistical analysis using Pearson/Spearman Test comparing MRI T2* values with ejection fraction and E/A ratio. Results: The median of 4-months mean of ferritin levels was 5130 ng/mL. The mean for cardiac T2* was 24.96 ms. Severe cardiac hemosiderosis (mean cardiac MRI T2* < 10 ms) occurred in 11.3% of the subjects. There was weak correlation between serum ferritin with cardiac iron toxicity (r=-0.272, p=0.032) and ejection fraction (r=-0.281, p=0.013). But, there was no correlation between cardiac iron toxicity with ejection fraction and E/A ratio. Conclusion: Serum ferritin correlated weakly with cardiac iron toxicity and cardiac systolic function. Meanwhile, there was no correlation between cardiac iron toxicity with cardiac systolic and diastolic function..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:53 |
---|---|
Enthalten in: |
Acta Medica Indonesiana - 53(2021), 3 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Tubagus Djumhana Atmakusuma [VerfasserIn] |
---|
Links: |
doaj.org [kostenfrei] |
---|
Themen: |
Cardiac iron toxicity |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
DOAJ061763705 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ061763705 | ||
003 | DE-627 | ||
005 | 20230309013629.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230228s2021 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)DOAJ061763705 | ||
035 | |a (DE-599)DOAJbd8e7489be9245edbcd5e273cbf0b62d | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RC31-1245 | |
100 | 0 | |a Tubagus Djumhana Atmakusuma |e verfasserin |4 aut | |
245 | 1 | 0 | |a Correlation of Serum Ferritin and Cardiac Iron Toxicity with Cardiac Function in Transfusion Dependent Beta-Thalassemia Major Patients |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Background: Cardiac iron toxicity is a major cause of mortality in transfusion-dependent beta-thalassemia major patients. The main modality for detecting cardiac iron toxicity is MRI T2* with limited availability. This study aims to obtain iron toxicity profiles in transfusion-dependent beta-thalassemia patients; to see a correlation between iron toxicity and cardiac function. Methods: We conducted a cross-sectional study at the Adult Thalassemia Polyclinic of Cipto Mangunkusumo Hospital, Indonesia from December 2017 to March 2018. We performed the statistical analysis using Pearson/Spearman Test comparing MRI T2* values with ejection fraction and E/A ratio. Results: The median of 4-months mean of ferritin levels was 5130 ng/mL. The mean for cardiac T2* was 24.96 ms. Severe cardiac hemosiderosis (mean cardiac MRI T2* < 10 ms) occurred in 11.3% of the subjects. There was weak correlation between serum ferritin with cardiac iron toxicity (r=-0.272, p=0.032) and ejection fraction (r=-0.281, p=0.013). But, there was no correlation between cardiac iron toxicity with ejection fraction and E/A ratio. Conclusion: Serum ferritin correlated weakly with cardiac iron toxicity and cardiac systolic function. Meanwhile, there was no correlation between cardiac iron toxicity with cardiac systolic and diastolic function. | ||
650 | 4 | |a cardiac iron toxicity | |
650 | 4 | |a serum ferritin | |
650 | 4 | |a systolic function | |
650 | 4 | |a diastolic function | |
650 | 4 | |a cardiac mri t2* | |
653 | 0 | |a Internal medicine | |
700 | 0 | |a Rajesh Kalwani |e verfasserin |4 aut | |
700 | 0 | |a Sally Aman Nasution |e verfasserin |4 aut | |
700 | 0 | |a Cleopas Martin Rumende |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Acta Medica Indonesiana |d Interna Publishing, 2013 |g 53(2021), 3 |w (DE-627)DOAJ000104299 |x 23382732 |7 nnns |
773 | 1 | 8 | |g volume:53 |g year:2021 |g number:3 |
856 | 4 | 0 | |u https://doaj.org/article/bd8e7489be9245edbcd5e273cbf0b62d |z kostenfrei |
856 | 4 | 0 | |u http://actamedindones.org/index.php/ijim/article/view/1782 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/0125-9326 |y Journal toc |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2338-2732 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 53 |j 2021 |e 3 |